Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
Danzi GB, Piccolo R, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Goicolea Ruigomez J, Sagic D, Laanmets P, Strupp G, West N; Nobori 2 Investigators. Danzi GB, et al. Among authors: wiemer m. Heart. 2017 Jan 15;103(2):111-116. doi: 10.1136/heartjnl-2016-309283. Epub 2016 Aug 10. Heart. 2017. PMID: 27511446
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators. Danzi GB, et al. Among authors: wiemer m. EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17. EuroIntervention. 2012. PMID: 22278136 Free article.
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.
Wiemer M, Stojkovic S, Samol A, Dimitriadis Z, Ruiz-Nodar JM, Birkemeyer R, Monsegu J, Finet G, Hildick-Smith D, Tresukosol D, Novo EG, Koolen JJ, Barbato E, Danzi GB; NOBORI 2 investigators. Wiemer M, et al. Cardiovasc Diabetol. 2017 May 4;16(1):59. doi: 10.1186/s12933-017-0541-7. Cardiovasc Diabetol. 2017. PMID: 28472961 Free PMC article. No abstract available.
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study.
Onuma Y, Tanimoto S, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Dorange C, Miquel-Hebert K, Veldhof S, Serruys PW. Onuma Y, et al. Among authors: wiemer m. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):634-42. doi: 10.1002/ccd.22541. Catheter Cardiovasc Interv. 2010. PMID: 20690152 Clinical Trial.
The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up.
Unverdorben M, Degenhardt R, Wiemer M, Horstkotte D, Schneider H, Nienaber C, Bocksch W, Gross M, Boxberger M, Vallbracht C; PECOPS I Investigators. Unverdorben M, et al. Among authors: wiemer m. Catheter Cardiovasc Interv. 2009 Nov 1;74(5):674-82. doi: 10.1002/ccd.22087. Catheter Cardiovasc Interv. 2009. PMID: 19530156 Clinical Trial.
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial.
Silber S, Gutiérrez-Chico JL, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Chevalier B, Serruys PW. Silber S, et al. Among authors: wiemer m. EuroIntervention. 2011 May;7(1):64-73. doi: 10.4244/EIJV7I1A13. EuroIntervention. 2011. PMID: 21550905 Free article. Clinical Trial.
142 results